ABCL holders · CITADEL ADVISORS LLC 13F · ABCL stock
CITADEL ADVISORS LLC Abcellera Biologics Inc (ABCL) 13F holding
CITADEL ADVISORS LLC reported 1,361,105 ABCL shares valued at $4.75B as of 2026-03-31 (COM). Cached 13F row, not a live tape.
| Report | Shares | Value | Class |
|---|---|---|---|
| 2026-03-31 | 1,361,105 | $4.75B | COM |
| 2026-03-31 | 429,500 | $1.50B | Call |
| 2026-03-31 | 87,200 | $304.3M | Put |
| 2025-12-31 | 1,834,508 | $6.27B | COM |
| 2025-12-31 | 222,000 | $759.2M | Call |
| 2025-12-31 | 175,100 | $598.8M | Put |
| 2025-09-30 | 1,008,615 | $5.07B | COM |
| 2025-09-30 | 237,300 | $1.19B | Call |
| 2025-09-30 | 236,400 | $1.19B | Put |
| 2025-06-30 | 2,695,461 | $9.25B | COM |
| 2025-06-30 | 243,000 | $833.5M | Put |
| 2025-06-30 | 194,299 | $666.4M | COM |
| 2025-06-30 | 37,800 | $129.7M | Call |
Not investment advice. Cached 13F row, not EDGAR XML.